Trading at just $1.54, IBIO looks like a penny stock—but behind the scenes, it’s building a biotech empire powered by AI-driven drug discovery targeting obesity, cancer, and heart disease.
🔬 Massive breakthroughs with partners like AstralBio
💥 Blockbuster pipeline with game-changing antibody tech
📈 Analyst price target: $86.53 – $170.69 in 2025
➡️ That’s over 11,000% upside from today’s price!
This isn’t hype—it’s deep science meeting smart money.
( i v a n p a t r i c e ) Also on t£l€gram